Boai NKY Shares Outstanding vs. Current Valuation
| 300109 Stock | 17.75 2.96 20.01% |
For Boai NKY profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Boai NKY to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Boai NKY Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Boai NKY's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Boai NKY Pharmaceuticals over time as well as its relative position and ranking within its peers.
Boai |
Boai NKY Pharmaceuticals Current Valuation vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Boai NKY's current stock value. Our valuation model uses many indicators to compare Boai NKY value to that of its competitors to determine the firm's financial worth. Boai NKY Pharmaceuticals is rated below average in shares outstanding category among its peers. It also is rated below average in current valuation category among its peers reporting about 15.15 of Current Valuation per Shares Outstanding. Comparative valuation analysis is a catch-all model that can be used if you cannot value Boai NKY by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Boai NKY's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Boai Current Valuation vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Boai NKY |
| = | 484.7 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Boai NKY |
| = | 7.34 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Boai Current Valuation vs Competition
Boai NKY Pharmaceuticals is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Materials industry is presently estimated at about 1.86 Trillion. Boai NKY adds roughly 7.34 Billion in current valuation claiming only tiny portion of all equities under Materials industry.
Boai NKY Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Boai NKY, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Boai NKY will eventually generate negative long term returns. The profitability progress is the general direction of Boai NKY's change in net profit over the period of time. It can combine multiple indicators of Boai NKY, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 3.5 B | 3.6 B | |
| Operating Income | 613 M | 643.6 M | |
| Income Before Tax | 614.1 M | 644.8 M | |
| Total Other Income Expense Net | 1.1 M | 1.2 M | |
| Net Income Applicable To Common Shares | 335.2 M | 351.9 M | |
| Net Income | 485.8 M | 510.1 M | |
| Income Tax Expense | 99.6 M | 104.6 M | |
| Net Interest Income | 10.6 M | 11.1 M | |
| Interest Income | 13.6 M | 14.5 M | |
| Net Income From Continuing Ops | 485.8 M | 510.1 M | |
| Change To Netincome | 83.2 M | 87.3 M |
Boai Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Boai NKY. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Boai NKY position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Boai NKY's important profitability drivers and their relationship over time.
Use Boai NKY in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Boai NKY position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boai NKY will appreciate offsetting losses from the drop in the long position's value.Boai NKY Pair Trading
Boai NKY Pharmaceuticals Pair Trading Analysis
The ability to find closely correlated positions to Boai NKY could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Boai NKY when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Boai NKY - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Boai NKY Pharmaceuticals to buy it.
The correlation of Boai NKY is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Boai NKY moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Boai NKY Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Boai NKY can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Boai NKY position
In addition to having Boai NKY in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Precious Metals Thematic Idea Now
Precious Metals
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Precious Metals theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Precious Metals Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Boai Stock
To fully project Boai NKY's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Boai NKY Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Boai NKY's income statement, its balance sheet, and the statement of cash flows.